How has been the historical performance of the Gayatri BioOrga.?

Answer:The historical performance of Gayatri BioOrga shows limited operational activity, with net sales recorded only in the fiscal year ending March 2023, amounting to Rs 1.67 crore. Since then, the company has not generated any sales revenue, and total operating income has remained at zero for the following years. The total expenditure, excluding depreciation, peaked at Rs 2.44 crore in March 2023 but has since decreased to Rs 0.45 crore in March 2025. Operating profit has consistently been negative, with the most recent figure at -Rs 0.45 crore in March 2025. The net profit has also remained negative, with a loss of Rs 0.73 crore in March 2025, following a loss of Rs 1.01 crore in March 2023. The company's equity capital has remained stable at Rs 78.79 crore, but reserves have been negative, reaching -Rs 114.68 crore in March 2025. The total assets have decreased from Rs 145.09 crore in March 2019 to Rs 1.58 crore in March 2024, indicating a significant decline in asset value. Cash flow from operating activities has been non-existent in recent years, with the last positive cash flow recorded in March 2020. Breakdown: Gayatri BioOrga's financial history reveals a company struggling with operational viability. The only recorded net sales occurred in March 2023, totaling Rs 1.67 crore, but this was followed by a complete halt in revenue generation. The total operating income has remained at zero since then, while total expenditure peaked in March 2023 before dropping significantly. Operating profit has been consistently negative, indicating ongoing losses, with the latest figure at -Rs 0.45 crore. The net profit has also shown a downward trend, culminating in a loss of Rs 0.73 crore in March 2025. The company's equity capital has remained unchanged, but reserves have turned increasingly negative, reflecting financial distress. Total assets have plummeted from Rs 145.09 crore in March 2019 to just Rs 1.58 crore in March 2024, highlighting a drastic reduction in asset value. Furthermore, cash flow from operating activities has been absent in recent years, with the last positive cash flow recorded in March 2020, underscoring the company's ongoing financial challenges.